Anbio Biotechnology Class A
(NASDAQ: NNNN)
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
40.830
+6.310
(+18.28%)
Range
36.488 - 42.990
(17.82%)
Open
37.400
Previous Close
34.520
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
84,060
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
